Clinical Trial Update: Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating patient-derived organoid-guided personalized treatment versus physician's choice in breast cancer is currently in recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Breast Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Breast Cancer, Refractory Breast Carcinoma | Phase 3 | Status: RECRUITING